Armata Pharmaceuticals (ARMP) Shareholder's Equity Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -479.34% |
| Dec 31, 2025 | -355.23% |
| Sep 30, 2025 | -87.53% |
| Jun 30, 2025 | -50.76% |
| Mar 31, 2025 | 4.83% |
| Dec 31, 2024 | -49.76% |
| Sep 30, 2024 | -311.54% |
| Jun 30, 2024 | -340.82% |
| Mar 31, 2024 | -351.75% |
| Dec 31, 2023 | -188.87% |
| Sep 30, 2023 | -127.18% |
| Jun 30, 2023 | -64.08% |
| Mar 31, 2023 | -63.52% |
| Dec 31, 2022 | 42.06% |
| Sep 30, 2022 | 91.86% |
| Jun 30, 2022 | 86.21% |
| Mar 31, 2022 | 80.93% |
| Dec 31, 2021 | 34.68% |
| Sep 30, 2021 | -3.51% |
| Jun 30, 2021 | -3.44% |
| Mar 31, 2021 | 1.58% |
| Dec 31, 2020 | 29.22% |
| Sep 30, 2020 | 35.78% |
| Jun 30, 2020 | 30.98% |
| Mar 31, 2020 | 746.57% |
| Dec 31, 2019 | 89.67% |
| Sep 30, 2019 | 106.14% |
| Jun 30, 2019 | 95.76% |
| Mar 31, 2019 | -73.11% |
| Dec 31, 2018 | -68.39% |
| Sep 30, 2018 | -9.85% |
| Jun 30, 2018 | 17.22% |
| Mar 31, 2018 | 121.21% |
| Dec 31, 2017 | 150.37% |
| Sep 30, 2017 | -46.47% |
| Jun 30, 2017 | -54.10% |
| Mar 31, 2017 | -25.28% |
| Dec 31, 2016 | -23.53% |
| Sep 30, 2016 | 16.38% |
| Jun 30, 2016 | 64.15% |